Seeking Alpha

Edwards Lifesciences (EW) wins approval from an FDA advisory panel for expanded use of its...

Edwards Lifesciences (EW) wins approval from an FDA advisory panel for expanded use of its Sapien artificial heart valve as an alternative to open heart surgery. The panel votes 11-0 that the benefits outweigh the risks of the transcatheter heart valve for patients considered high-risk yet who are capable of handling surgery. EW +0.5% premarket.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)